Neurodevelopmental Effects of Antiepileptic Drugs

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Neurochemical Research

• Publication date

  2017-04-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11064-017-2262-4PMID 28424947PMCID PMC6390972
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antiepileptic drugs

  2016cited by this paper
• The importance of assessing behaviour and cognition in antiepileptic drug trials in children and adolescents

  2016cited by this paper
• Developmental effects of antiepileptic drugs and the need for improved regulations

  2016influential reference
• Evidence for spared attention to faces in 7-month-old infants after prenatal exposure to antiepileptic drugs.

  2016cited by this paper
• Neurodevelopmental Effects of Fetal Antiepileptic Drug Exposure

  2015cited by this paper
• Cognitive outcomes of prenatal antiepileptic drug exposure.

  2015cited by this paper
• Epilepsy and recommendations for breastfeeding.

  2015cited by this paper
• A systematic review of placebo‐controlled trials of topiramate: How useful is a multiple‐indications review for evaluating the adverse events of an antiepileptic drug?

  2015cited by this paper
• IQ at 6 years after in utero exposure to antiepileptic drugs

  2015cited by this paper
• Prospective assessment of autism traits in children exposed to antiepileptic drugs during pregnancy

  2015cited by this paper
• Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years.

  2014cited by this paper
• Developmental neurotoxicity and anticonvulsant drugs: a possible link.

  2014cited by this paper
• Evaluation of neurotoxic and neuroprotective pathways affected by antiepileptic drugs in cultured hippocampal neurons.

  2013cited by this paper
• Certain secondary antiepileptic drugs can rescue hippocampal injury following a critical growth period despite poor anticonvulsant activity and cognitive deficits.

  2013cited by this paper
• Exposure to antiepileptic drugs in utero and child development: A prospective population‐based study

  2013cited by this paper
• The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs

  2013cited by this paper
• Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism.

  2013cited by this paper
• Developmental outcomes at preschool age after fetal exposure to valproic acid and lamotrigine: cognitive, motor, sensory and behavioral function.

  2013cited by this paper
• Impact of early life exposure to antiepileptic drugs on neurobehavioral outcomes based on laboratory animal and clinical research.

  2013cited by this paper
• Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study.

  2013cited by this paper
• Language skills of school-aged children prenatally exposed to antiepileptic drugs

  2011cited by this paper
• Effects of Neonatal Antiepileptic Drug Exposure on Cognitive, Emotional, and Motor Function in Adult Rats

  2011cited by this paper
• Interventions for latent autoimmune diabetes (LADA) in adults.

  2011cited by this paper
• Fetal antiepileptic drug exposure: Adaptive and emotional/behavioral functioning at age 6years.

  2011cited by this paper
• Pattern of antiepileptic drug–induced cell death in limbic regions of the neonatal rat brain

  2011cited by this paper
• Relationship of child IQ to parental IQ and education in children with fetal antiepileptic drug exposure.

  2011cited by this paper
• Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.

  2010cited by this paper
• Early cognitive development in children born to women with epilepsy: A prospective report

  2010cited by this paper
• Management issues for women with epilepsy—Focus on pregnancy (an evidence‐based review): II. Teratogenesis and perinatal outcomes

  2009cited by this paper
• In utero antiepileptic drug exposure: Fetal death and malformations

  2007cited by this paper
• In utero antiepileptic drug exposure

  2006cited by this paper
• The Cochrane Database of Systematic Reviews

  2006cited by this paper
• A note on Pierre Marie (1853–1940)

  2004cited by this paper
• Antiepileptic drugs and apoptotic neurodegeneration in the developing brain

  2002cited by this paper
• Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome.

  2000cited by this paper
• Neural and behavioral alterations after early exposure to phenobarbital.

  1989cited by this paper
• Anticonvulsant drugs and congenital abnormalities.

  1968cited by this paper

• Antiseizure Medication Dosing Strategy During Pregnancy and Early Postpartum in Women With Epilepsy in MONEAD.

  2026cites this paper
• Pharmacokinetic variability of antiepileptic drugs in neonates: A narrative review

  2025cites this paper
• Effect of in utero exposure to antiepileptic drugs on cortical networks and neurophysiological outcomes at 6 years

  2024cites this paper
• Element Changes Occurring in Brain Point at the White Matter Abnormalities in Rats Exposed to the Ketogenic Diet During Prenatal Life

  2024cites this paper
• Epilepsy and childhood psychiatric disorders: a two-sample bidirectional Mendelian randomization study

  2024cites this paper
• Maternal epilepsy and pregnancy, delivery and neonatal outcomes: A population-based retrospective cohort study.

  2024cites this paper
• Alterations in spatiotemporal characteristics of dynamic networks in juvenile myoclonic epilepsy

  2024cites this paper
• Intracerebral delivery of antiseizure medications by microinvasive neural implants.

  2024cites this paper
• Issues of Women with Epilepsy and Suitable Antiseizure Drugs

  2023cites this paper
• Exposure to medication for neurological disease in pregnancy – time to consider the long-term implications?

  2023cites this paper
• What are the considerations when initiating treatment for epilepsy in children?

  2023cites this paper
• Does Ketogenic Diet Used in Pregnancy Affect the Nervous System Development in Offspring?—FTIR Microspectroscopy Study

  2023cites this paper
• Association between neurodevelopmental outcomes and concomitant presence of NEC and IVH in extremely low birth weight infants

  2023cites this paper
• Does maternal genetic liability to folate deficiency influence the risk of antiseizure medication-associated language impairment and autistic traits in children of women with epilepsy?

  2023cites this paper
• Perbedaan Fungsi Kognitif pada Pasien Anak dengan Epilepsi yang Mendapatkan Monoterapi dan Politerapi di Rumah Sakit Umum Daerah Moewardi Surakarta

  2023cites this paper
• Clinical Outcome Data of Children Treated with Cannabis-Based Medicinal Products for Treatment Resistant Epilepsy—Analysis from the UK Medical Cannabis Registry

  2022cites this paper
• Plasma unmetabolized folic acid in pregnancy and risk of autistic traits and language impairment in antiseizure medication–exposed children of women with epilepsy

  2022cites this paper
• The Effect of Camel Milk on Social Interaction and Repetitive Behaviors of Valproic acid-induced Autistic Rats

  2022cites this paper
• Low reliability of DNA methylation across Illumina Infinium platforms in cord blood: implications for replication studies and meta-analyses of prenatal exposures

  2022cites this paper
• Effects of Maternal Use of Antiseizure Medications on Child Development.

  2022cites this paper
• The Role of Epigenetics in the Pathogenesis and Potential Treatment of 
Attention Deficit Hyperactivity Disorder

  2021cites this paper
• Vitamin B status and association with antiseizure medication in pregnant women with epilepsy

  2021cites this paper
• Impact of In Utero Exposure to Antiepileptic Drugs on Neonatal Brain Function

  2021cites this paper
• Use of levetiracetam in neonates

  2021cites this paper
• Epilepsy and pregnancy: What should the neurologists do?

  2021cites this paper
• The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond

  2021cites this paper
• Neurocognitive Effects of Antiseizure Medications in Children and Adolescents with Epilepsy

  2021cites this paper
• Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Intellectual Disability and Delayed Childhood Milestones

  2020cites this paper
• Remarkable effect of transdermal nicotine in children with CHRNA4-related autosomal dominant sleep-related hypermotor epilepsy.

  2020cites this paper
• Functional Language Network Connectivity in Children of Women with Epilepsy with Selective Antenatal Antiepileptic Drug Exposure

  2020cites this paper
• Inter-rater reliability of amplitude-integrated EEG for the detection of neonatal seizures.

  2020cites this paper
• Médicaments et grossesse, impacts fœtaux et néonatals

  2020cites this paper
• An update on maternal medication‐related embryopathies

  2020cites this paper
• Why do neonates receive antiseizure medications?

  2020cites this paper
• Seizure mimics in children: An age-based approach.

  2020cites this paper
• Prise en charge thérapeutique des adolescents atteints d'épilepsie généralisée idiopathique dans une cohorte Marseillaise suivie entre 2001 et 2019

  2020cites this paper
• Measuring Real-Time Medication Effects From Electroencephalography

  2020cites this paper
• Enhancing effect of aerobic training on learning and memory performance in rats after long-term treatment with Lacosamide via BDNF-TrkB signaling pathway.

  2019cites this paper
• Perinatal outcome and healthcare resource utilization in the first year of life after antiepileptic exposure during pregnancy.

  2019cites this paper
• Neurological diseases in pregnancy

  2019cites this paper
• Language impairment in children aged 5 and 8 years after antiepileptic drug exposure in utero – the Norwegian Mother and Child Cohort Study

  2019influential citation
• Why we urgently need improved seizure and epilepsy therapies for children and neonates.

  2019cites this paper
• Why do some women with epilepsy use valproic acid despite current guidelines? A single-center cohort study.

  2019cites this paper
• Parent Reported Executive Functioning Does Not Predict Memory Dysfunction in Pediatric Epilepsy and Attention-Deficit/Hyperactivity Disorder By

  2018cites this paper
• Latest clinical recommendations on valproate use for migraine prophylaxis in women of childbearing age: overview from European Medicines Agency and European Headache Federation

  2018cites this paper
• In utero exposure to antiepileptic drugs is associated with learning disabilities among offspring

  2018cites this paper
• Effect of Ketogenic Diet on Motor Functions and Daily Living Activities of Children With Multidrug-Resistant Epilepsy: A Prospective Study

  2018cites this paper
• Psychoactive drug exposure during breastfeeding: a critical need for preclinical behavioral testing

  2018cites this paper
• Declining trend in valproate use in Finland among females of childbearing age in 2012–2016 – a nationwide registry‐based outpatient study

  2018cites this paper
• Discontinuation of antiepileptic drugs in seizure-free patients - when and how?

  2017cites this paper
• Women with epilepsy.

  2016cites this paper
• Pediatric epilepsy surgery: could age be a predictor of outcomes?

  2016cites this paper
• ESTUDO CLÍNICO, GENÉTICO E FARMACOLÓGICO NA SÍNDROME DE DRAVET: relato de caso

  2016cites this paper
• Management of epilepsy during pregnancy: evidence-based strategies.

  2015cites this paper
• Protective role of biological potential curcumin in epileptic seizures and memory impairment

  2015cites this paper